genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Supplement
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Gene Therapy
Laying the Foundation for CF Therapy: An Interview with Michael Boyle
Coronavirus
Beyond the Spike: The COVAXX Approach to a COVID-19 Vaccine
Bioprocessing
Cytiva Plans $500M Expansion, 1,000 New Hires Worldwide
Coronavirus
A ‘Human’ Touch vs. COVID-19
Gene Therapy
AGTC Sets Sights on Late-Stage Retinitis Pigmentosa Gene Therapy Trial
News
Antibacterials
Dangerous E. coli Strain Reveals Potential New Drug Target
Antibacterials
Genome of Fleming’s Original Penicillium Strain Could Point to New Routes…
OMICs
Scientists Build Most Extensive Cell Atlas of the Human Heart
Artificial Intelligence
How AI Scratches More Than Just the Surface in Neurodegeneration
Cancer
Blueberry Compound May Provide New Inflammatory Bowel Disease Therapy
Insights
All
Trends for 2020
Bioprocessing
Novel Tech Approaches for Analyzing Aggregation
Bioprocessing
Data Management in the DNA of New Gene Therapy Plant
Bioprocessing
Personalized Medicine Manufacturing Needs “Debugging Tools”
A-Lists
Top 50 NIH-Funded Institutions of 2020
A-Lists
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Coronavirus
Blinking Red: 25 Missed Pandemic Warning Signs
Coronavirus
Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Antibacterials
Dangerous E. coli Strain Reveals Potential New Drug Target
Antibacterials
Genome of Fleming’s Original Penicillium Strain Could Point to New Routes…
OMICs
Scientists Build Most Extensive Cell Atlas of the Human Heart
Cancer
Blueberry Compound May Provide New Inflammatory Bowel Disease Therapy
Magazine
All
Supplement
September 2020 Vol. 40 No. 9
Cold Cases Heat Up with New Forensic DNA Methods
September 2020 Vol. 40 No. 9
CRISPR Value Chains Support New Therapeutic Strategies
September 2020 Vol. 40 No. 9
Nonviral CRISPR Delivery Vehicles Lay the Smart Siege
Point of View
Multimodal Screening—The Future of Drug Discovery and Development
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Molecular Diagnostics/In vitro Diagnostics
Companion Diagnostics
Companion Diagnostics
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Companion Diagnostics
FDA Approves Guardant Test as First Pan-Cancer Liquid Biopsy, CDx for AstraZeneca’s Tagrisso
Companion Diagnostics
Illumina, Roche Launch NGS-Based Cancer Diagnostics Partnership
Companion Diagnostics
FDA Approves Tecentriq-Abraxane Combo as First Immunotherapy Regimen for Breast Cancer
Companion Diagnostics
New Thermo Fisher Center Offers Access to Precision Medicine Technologies, Expertise
Companion Diagnostics
FDA Extends Approval for Qiagen NSCLC Test as CDx to Boehringer Ingelheim’s Gilotrif
Companion Diagnostics
Pfizer Joins Foundation Medicine to Develop Cancer CDx
Companion Diagnostics
FDA, CMS Approve Foundation Medicine’s Solid Tumor Test with Proposed Coverage
Companion Diagnostics
Illumina’s Jay Flatley: In “Shock and Awe” at State of Personalized...
Companion Diagnostics
FDA Clears Thermo Fisher NGS Companion Diagnostic for Three NSCLC Treatments
Companion Diagnostics
CDx for Agios Cancer Candidate to Be Developed by Thermo Fisher...
Companion Diagnostics
Clovis Partners with Myriad on Diagnostic for Ovarian Cancer Treatment
Companion Diagnostics
R-Biopharm, Merck KGaA Launch Companion Diagnostics Collaboration
Companion Diagnostics
Apogenix Wins $3.3M Grant toward Trial of Lead Product, CDx Validation
Companion Diagnostics
NanoString, Medivation, and Astellas to Develop Breast Cancer CDx
Companion Diagnostics
Thermo Fisher Scientific Launches CDx Alliance with Novartis, Pfizer
Load more
Scroll Up
Please share your location to continue
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
![Drug resistant E. coli could be rapidly detected using newly developed technique. [NIH]](https://www.genengnews.com/wp-content/uploads/2018/08/24661308922_3eb66388f6_o8020087571-218x150.jpg "Dangerous E. coli Strain Reveals Potential New Drug Target")
